LIVE
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video
Biogen stock plunge shows 'investment model in drug development is all wrong,' says former Aetna CEO
Business
March 22, 2019
This article is being updated.
Previous article: Nike shares are falling as the sneaker maker warns of a sales slowdown
Prev
Next article: New York Times CEO warns publishers on the dangers of partnering with Apple
Next
via
CNBC
March 22nd 2019
MixedTimes.com
Business
Biogen stock plunge shows 'investment model in drug development is all wrong,' says former Aetna CEO
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video